ArticleJournal of enzyme inhibition and medicinal chemistry2018

Design, synthesis and biological evaluation of 4-bromo-N-(3,5-dimethoxyphenyl)benzamide derivatives as novel FGFR1 inhibitors for treatment of non-small cell lung cancer.

Zixin Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.